The wire › SEC Form 8-K
TNF Pharmaceuticals, Inc. TNFA
Filed with the SEC on Mar 21, 2025. Reported event date Mar 17, 2025.
- Business address
- New York, NY
- State
- New York
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2835)
- SEC CIK
- 1321834
- Accession number
- 0001493152-25-011160
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing